Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-07

Clinical Trial Update: Erbium-doped Yttrium Aluminium Garnet Laser(Er:Yag)Associated With Amorolfine Lacquer in the Treatment of Onychomycosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of an Er:YAG laser with amorolfine lacquer for the treatment of onychomycosis; the current status is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amorolfine lacquer (amorolfine)

Snippet

Sponsor: Brasilia University Hospital | Conditions: Onychomycosis | Phase 2 | Status: UNKNOWN